Topics

Rosetta Genomics, Ltd. Company Profile

03:28 EST 22nd November 2019 | BioPortfolio

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company’s first three microRNA-based tests, miRview™ squamous, miRview™ mets and miRview™ meso, are commercially available through its Philadelphia-based CAP accredited, CLIA-certified lab. Rosetta Genomics is the 2008 winner of the Wall Street Journal’s Technology Innovation Awards in the medical/biotech category. To learn more, please visit www.rosettagenomics.com .


News Articles [453 Associated News Articles listed on BioPortfolio]

High-Performance Benefits Group Health Rosetta Headlines Wake-Up Call Event in Phoenix

PHOENIX (PRWEB) May 24, 2019 Health Rosetta will host its upcoming Phoenix Wake-Up Call on Wednesday, May 29 at the Arizona Country ...

Cyrus Biotechnology Offers CryoEM Services Based on First-in-class, Peer-reviewed Rosetta Software Methods

Cyrus Biotechnology, Inc., a Seattle-based biotech software company specializing in the use and commercialization of Rosetta, the world's leading computational protein design platform, announces the ...

Novel EU-funded project in the field of genomics

The European Advanced infraStructure for Innovative Genomics (EASI-Genomics), a project funded under the European Union's research and innovation programme Horizon 2020, will provide researchers free-...

Cyrus Biotechnology Integrates DNA/RNA Support into Its Rosetta-based Protein Design Platform

Cyrus Biotechnology, Inc., a Seattle-based biotech software company commercializing Rosetta, the most advanced computational protein design platform, is announcing the release of ...

Medicinal Genomics signs Tagaca SRL as distribution partner

Medicinal Genomics Corp. (MGC), a pioneer in genomics and blockchain technology to improve the yield, safety and transparency of cannabis, today announced its partnership with Tagaca SRL as The post ...

QUANTUM GENOMICS: Quantum Genomics Announces the Publication of a New Scientific Article in the Journal Hypertension

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypert...

QUANTUM GENOMICS: Quantum Genomics Launches Study of Firibastat in Patients with Renal Failure

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that a directly targets the brain to treat resistant hypertension...

A Roadmap and Wish List for Synthetic Genomics

Within the huge synthetic biology world is an enormous variety of ideas and approaches, like custom-made proteins, CAR-T medicines, genetically engineered crops, and more. One sector still in its infa...

Drugs and Medications [0 Results]

None

PubMed Articles [268 Associated PubMed Articles listed on BioPortfolio]

Expression and purification of soluble and functional fusion protein DAB IL-2 into the E. coli strain Rosetta-gami (DE3).

DAB IL-2 (Denileukin diftitox) is considered an immunotoxin and it is the first immunotoxin approved by FDA. It is used for the treatment of a cutaneous form of T cell lymphoma (CTCL). This fusion pro...

Trends in Genomics & Informatics: a statistical review of publications from 2003 to 2018 focusing on the most-studied genes and document clusters.

Genomics & Informatics (NLM title abbreviation: Genomics Inform) is the official journal of the Korea Genome Organization. Herein, we conduct a statistical analysis of the publications of Genomics & I...

Australian Genomics: A Federated Model for Integrating Genomics into Healthcare.

Australian Genomics is a national collaborative research partnership of more than 80 organizations piloting a whole-of-system approach to integrating genomics into healthcare that is based on federati...

Plasmodium comparative genomics.

Changing the biological Rosetta stone: the (commercial) potential of recoded microbes.

Clinical Trials [120 Associated Clinical Trials listed on BioPortfolio]

RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial

The ROSETTA-trial will evaluate the effect of acupuncture as a complementary treatment parallel to radiation therapy in oncological patients. The trial is designed as a two-armed trial. De...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Radiogenomic and Prognosis Analysis in Glioma

This study aims to evaluate whether MRI can be used to predict genomics and prognosis in glioma. Given the profound prognostic significance of genetic mutations seen in glioma, there have ...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Effectiveness of Web-based Genomic Nursing Education Intervention

There is a research gap of integrating genomics into nursing practice, education and research. Nursing students seldom use genetic-genomic data for understanding the individuality of patie...

Companies [436 Associated Companies listed on BioPortfolio]

Rosetta Genomics

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics Ltd.

Rosetta Genomics (NASDAQ: ROSG) is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinfo...

Rosetta Genomics, Ltd.

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics Ltd. and Biocept, Inc.

Rosetta develops and commercializes a full range of microRNA-based and other molecular diagnostics. Rosetta’s integrative research platform combining bioinformatics and state...

Rosetta Stone Inc.

Rosetta Stone Inc. is changing the way the world learns languages. Rosetta Stone provides interactive solutions that are acclaimed for the speed and power to unlock the natural la...

More Information about "Rosetta Genomics, Ltd." on BioPortfolio

We have published hundreds of Rosetta Genomics, Ltd. news stories on BioPortfolio along with dozens of Rosetta Genomics, Ltd. Clinical Trials and PubMed Articles about Rosetta Genomics, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rosetta Genomics, Ltd. Companies in our database. You can also find out about relevant Rosetta Genomics, Ltd. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...


Corporate Database Quicklinks



Searches Linking to this Company Record